Clinical trial NCT06570928
Status: Completed, results awaitedPhase 2Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: Use of a Cannabinoids as a Treatment Strategy for Alzheimer's Disease
- Record number
- NCT06570928
- Status
- Completed, results awaited
- Type and phase
- Clinical trial, phase 2
- Participants
- 72 (actual)
- Condition (as registered)
- Alzheimer Disease
- Countries
- Brazil
- Topic in the guide
- Dementia
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: August 13, 2024
- End of data collection for primary results: August 27, 2024
- Trial completion: March 27, 2025
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Completed, results awaited.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Dementia: ongoing trials · Thinking of taking part? Which specialist to see